(Date:11/21/2008)...RSBURG, Fla., Nov. 21 Mayor Rick B...l are partnering with the American Lung Associatio...enza initiative to educate St. Petersburg and Tam...al vaccination to help protect themselves and thei...pport of the initiative, Mayor Baker, Council Chai...
(Date:11/21/2008)...la., Nov. 21 Unilens Vis...Exchange: UVI), which develops, licenses,manufac...enses, today reported,its operating results for t.... , Net sales, excluding royalty income, in...r, compared with $1,673,361 in the previous year f...
(Date:11/21/2008)...ll easier to take, has fewer side effects than ch... 21 (HealthDay News) -- The cancer-fighting pill I...ne treatment for lung cancer, researchers report. ...yond eight months, Iressa (gefitinib) causes fewer...or patients who did not do well on their first rou...
(Date:11/21/2008)..., Nov. 21 Keryx Biopharm... that on November 17, 2008, it received notice fro...the Company is no longer in compliance with Market...to have a minimum of $2,500,000 in stockholders, e...ities, or $500,000 of net income from continuing o...
Breaking Medicine News(10 mins):Health News:Mayor Rick Baker and the American Lung Association Encourage St. Petersburg Residents to Get Immunized Against Influenza 2Health News:Mayor Rick Baker and the American Lung Association Encourage St. Petersburg Residents to Get Immunized Against Influenza 3Health News:Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income 2Health News:Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income 3Health News:Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income 4Health News:Iressa as Good as Chemotherapy for Lung Cancer 2Health News:Iressa as Good as Chemotherapy for Lung Cancer 3Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 2Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 3(Date:11/12/2008)...12 A new study being,pu...ll help answer the,question, what causes Parkinson...n the medical research into,Parkinson,s disease is...ie,in the first place. Answering this question has...early identical types of brain cells that produce,...
(Date:11/12/2008)... and LOD, Israel, November 12 Surg..., NY indicated that,patient-specific CTA data can ...entor(TM), Simbionix US) with high face validity. ... improved the operative flow,increased patient sa...verall operative and fluoroscopy time and the amou...
(Date:11/12/2008)...en Label Study and New Data Suggesting Need for Im...08 Annual Meeting -, EXTON, Pa., Nov. 12 /PRNewsw... VPHM ) today announced the presentation of data ...n this study Cinryze(TM) C1 inhibitor,therapy succ...ioedema (HAE),attacks seen in the study through th...
(Date:11/12/2008)... The Miami Jewish Home and Hospital...inical Research today,announced that they are acti... Phase 3 clinical trial that is evaluating the saf...on as a treatment for mild-to-moderate,Alzheimer,s...zheimer,s Association, more than,5 million people ...
Breaking Medicine Technology:A Window Into Parkinson's Disease 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 3ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 4ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 5ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 6Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 276 1Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 276 2Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 276 3Study finds limiting work hours for surgical residents enhances training 1351 1Study finds limiting work hours for surgical residents enhances training 1351 2Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 1Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 2Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 3BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends 603 1BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends 603 2...T, June 11, 2007 (MARKET WIRE via COMTEX News,Netw...arget=,"_blank" href="http://www.myriad.com/">www....athematical comparison of a,"Staggered Start" and ...th a "Natural History Staggered Start" clinical tr...on Conference held,June 9 - 12, 2007, in Washingto...
...INESS WIRE)--Jun 12, 2007 - Inspire,Pharmaceutical...ists and collaborators related to Inspire will pre...ean Academy of,Allergology and Clinical Immunology...weden and at the 30th European Cystic Fibrosis,Soc... in Belek,Turkey., The EAACI Congress includes tw...
Other Medicine Technology:Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3An excellent preventative/thera-peutic device for wearing during sports or construction activity. Helps dampen vibration and shock often transmitted during periods of repetitive motion. Provides re
...controlling range of motion of the elbow., ,While...remity bracing solutions, in recent years an incre...custom and post-operative elbow stabilization brac...braces come in single hinge and dual hinge designs...
Premium Tennis Elbow Support is 2" wide with loop-lock contact closure and is foam-lined for comfort.
...Joint Technology" elbow brace has been designed by...h pain free range of motion. ,The SADER II Elbow/F...inician and patient with adjustable static and dyn... and Forearm Fractures, Post Surgical loss of Moti...
Medicine Products: